In studies mainly on non-CKD population, sclerostin levels were correlated positively with age, male sex, diabetes, and bone mineral density (BMD) but inversely with physical activity and parathyroid hormone (PTH) levels [10–14]. Here, SOST is linked to chronic kidney disease.